Evaluation of intravenous and intramuscular efficacy in childhood immune thrombocytopenic purpura

被引:0
|
作者
Mori, PG
Biglino, P
Boeri, E
Calvi, A
Dufour, C
Lavagetto, A
Molinari, AC
Valetto, A
Gabutti, N
Ramenghi, U
Miano, C
De Mattia, D
机构
[1] Univ Turin, Pediat Clin, Hematol Sect, Turin, Italy
[2] Childrens Hosp Bambin Gesu, Hematol Sect, Rome, Italy
[3] Univ Bari, Pediat & Prevent Clin, Bari, Italy
[4] Gaslini Childrens Hosp, Div Pediat, Hematol Section 4, Genoa, Italy
关键词
D O I
10.1203/00006450-199906000-00251
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
A4
引用
收藏
页码:939 / 939
页数:1
相关论文
共 50 条
  • [31] Efficacy and safety of a new intravenous immunoglobulin product in patients with chronic immune thrombocytopenic purpura
    Robak, Tadeusz
    Salama, Abdulgabar
    Kovaleva, Lidia
    Vyhovska, Yaroslava I.
    Davies, Simon
    Mazzucconi, Maria G.
    Zenker, Othmar
    BLOOD, 2007, 110 (11) : 393A - 394A
  • [32] Safety and efficacy of intravenous immunoglobulin (Flebogamma® 10% DIF) in patients with immune thrombocytopenic purpura
    Apte, Shashikant
    Navarro-Puerto, Jordi
    Damodar, Sharat
    Ramanan, Vijay
    John, Joseph
    Kato, Giraldo
    Ross, Cecil
    Shah, Chirag
    Torres, Marcela
    Fu, Chieh-Lin 'Kathy'
    Rucker, Karen
    Pinciaro, Paul
    Barrera, Gladis
    Esperanca Aragones, Maria
    Ayguasanosa, Jaume
    IMMUNOTHERAPY, 2019, 11 (02) : 81 - 89
  • [33] Efficacy and safety of different doses and durations of intravenous immunoglobulin treatment for immune thrombocytopenic purpura
    Lavon, O.
    Noy, R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2019, 75 : S31 - S31
  • [34] The treatment of idiopathic thrombocytopenic purpura in adults: The efficacy of domestic intravenous immunoglobulin in immune thrombocytopenia
    Pugina, SA
    Evdokimova, NM
    Rastorguev, GG
    Samoilova, OS
    Sorokina, IV
    Sidnev, GV
    Vasilyev, DM
    Anastasiev, VV
    Milovidova, OV
    Molodovskaya, EV
    Borovkov, NN
    TERAPEVTICHESKII ARKHIV, 1999, 71 (08) : 50 - 54
  • [35] Alternatives to intravenous immunoglobulins in the treatment of immune thrombocytopenic purpura
    David, M
    Chevalier, I
    VOX SANGUINIS, 2002, 83 : 443 - 445
  • [36] Mechanisms of intravenous immunoglobulin action in immune thrombocytopenic purpura
    Jin, F
    Balthasar, JP
    HUMAN IMMUNOLOGY, 2005, 66 (04) : 403 - 410
  • [37] Corticosteroid prophylaxis for neurologic complications of intravenous immunoglobulin G therapy in childhood immune thrombocytopenic purpura
    Jayabose, S
    Mahmoud, M
    Levendoglu-Tugal, O
    Sandoval, C
    Ozkaynak, F
    Giamelli, J
    Visintainer, P
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1999, 21 (06) : 514 - 517
  • [38] Vaccino-associated immune thrombocytopenic purpura in childhood
    Petrov, V
    Vdovin, V
    Svirin, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 125 : 50 - 50
  • [39] Childhood chronic immune thrombocytopenic purpura: Unresolved issues
    Blanchette, VS
    Price, V
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2003, 25 : S28 - S33
  • [40] Use of rituximab in chronic childhood immune thrombocytopenic purpura
    Bay, Ali
    Oner, Ahmet Faik
    Uner, Abdurrahman
    Dogan, Murat
    PEDIATRICS INTERNATIONAL, 2006, 48 (05) : 514 - 516